News

We actively communicate on our business, services and technical capabilities. Use the resources on this page to browse through recent news, to subscribe to our news services or to meet us at one of our forthcoming events.

Business news

Alzinova testimonial: Alzheimer’s peptide vaccine with PolyPeptide

1 Sep 2025 - September is International Alzheimer’s Month, a reminder of the urgent need to advance research and treatment options for patients and families affected worldwide. It is an […]

Read more
Expert views

Backbone Protecting Groups for Enhanced Peptide and Protein Synthesis

13 Aug 2025 - This review provides a comprehensive account of the use of backbone N-protecting groups in peptide synthesis. It includes detailed synthetic methods relating to their introduction and removal […]

Read more
Ad hoc announcements pursuant to Art. 53 LR

PolyPeptide delivers +24% growth in H1 2025, successful ramp-up at its Belgian site, 2025 full-year guidance revised towards the upper end of the range

12 Aug 2025 - Baar, 12 August 2025 – PolyPeptide Group AG (SIX: PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, today announced its results for H1 2025, […]

Read more
Media releases

PolyPeptide announces expansion of existing credit facilities

23 May 2025 - Baar, 23 May 2025 – PolyPeptide Group AG (SIX: PPGN), a specialized, global CDMO for peptide-based active pharmaceutical ingredients, today announced that it has secured additional […]

Read more
Business news

Alzinova Advances ALZ-101 Development with Drug Substance Release, Paving the Way for Phase 2 Clinical Trial

24 Apr 2025 - Sweden, 24 April 2025 – Alzinova AB (publ) (ticker: ALZ) is pleased to announce the release of the drug substance for its upcoming Phase 2 clinical […]

Read more
Media releases

PolyPeptide announces results of the annual General Meeting 2025

9 Apr 2025 - Baar, 9 April 2025 – PolyPeptide Group AG (SIX: PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, today announced that the shareholders approved all […]

Read more
Expert views

Expanding the Reach of Sustainable Solid-Phase Peptide Synthesis

2 Apr 2025 - Alloc protecting group expanded the peptide synthesis toolbox. Its removal can sometimes be seen as an issue: toxic solvents, air-sensitive Pd0) reagents, challenging upscaling. Not anymore […]

Read more
Expert views

Impurities in Peptide Drug Substance and Challenges Faced during Registration (in US, EU, Brazil and China Markets) and Commercial Phase

20 Mar 2025 - Controlling impurities in complex drug substances is a crucial part of development and due to lack of harmonized approaches from Health authorities, the manufacturer faces many […]

Read more
Media releases

PolyPeptide publishes invitation to the annual General Meeting 2025

18 Mar 2025 - Baar, 18 March 2025 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide-based active pharmaceutical ingredients, published today the invitation to the fourth […]

Read more